Historic Aussie-first breakthrough in fight against condition impacting 40 million
In a groundbreaking leap forward in the global fight against HIV, researchers at Melbourne's world-renowned Doherty Institute have developed a revolutionary method that could one day pave the way for a cure, using the same mRNA technology that powered COVID-19 vaccines.
This discovery gives fresh hope to the nearly 40 million people around the world living with HIV. While today's treatments can keep the virus under control, they can't remove it completely. That's because HIV hides in a type of white blood cell, staying asleep and undetectable. But if treatment stops, the virus can wake up and spread again.
For decades, this hidden "reservoir" has been one of the biggest obstacles to finding a cure.
Now, researchers believe they've found a way to reach these sleeping cells and wake the virus up in a safe and controlled way, while the patient is still on their usual medication.
Speaking to Yahoo News Australia, Dr Michael Roche, a Senior Research Fellow at the Doherty Institute, explained how his team used mRNA wrapped inside tiny fat-like bubbles called lipid nanoparticles. These nanoparticles are designed to travel directly to infected cells. Once inside, the mRNA sends instructions to the cell to make a protein called Tat — a natural HIV protein that tells the virus it's time to wake up.
"Tat is a protein that helps the virus 'wake up' when the virus wants to," Dr Roche said. "Here we are using Tat to wake the virus up when we want to."
This process is often called the "shock and kill" strategy. The idea is to force the virus out of hiding while the patient is still on HIV medication, so the virus can't spread and can instead be targeted and destroyed by the immune system or future therapies.
The discovery is still in early stages, but it's the first time mRNA has successfully reached and activated the HIV reservoir in a lab setting. The team's next step is to test the treatment in animal models to check if it's safe and if it works.
"We are looking for two signals," Dr Roche said. "Firstly, safety. Secondly, efficacy — whether it can wake up dormant HIV in animals."
These trials will take a few years. Only after passing those tests can human trials begin — first to ensure the treatment is safe, and then to test how well it works in people.
A key advantage is that this therapy uses the same technology that powered the COVID-19 vaccine rollout. "Our therapeutic is based on the same technology — mRNA and lipid nanoparticles — used in the COVID vaccines," Dr Roche said. "The global rollout of these vaccines has shown that this approach can be scaled and distributed globally."
He pointed to a new BioNTech mRNA facility in Rwanda, which is being set up to support production in areas with a high burden of HIV. The team is also focused on making sure the treatment, if successful, can be made affordable and accessible. "We are committed to ensuring any cures we develop are scalable, accessible and affordable," Dr Roche said.
Aussies warned over widespread danger emerging in homes
Concerning roadside find reveals dangerous trend landing Aussies in hospital
Controversial 'alcohol alternative' coming to Woolworths this month
In Australia, around 29,000 people are living with HIV. New infections have dropped over the past decade thanks to wider access to HIV prevention medication (PrEP), regular testing, and strong treatment programs.
The country recorded its lowest number of new HIV cases in over 20 years in 2022. But some challenges remain. In 2023, there was a slight increase in new cases, mostly among people born overseas and those infected through heterosexual contact. Still, the long-term trend is positive, and now, with this research, a cure no longer feels out of reach.
If successful, this approach could one day mean people living with HIV no longer need daily medication, and may even be able to live completely free of the virus. As the world watches closely, Australia's scientists are once again leading the charge.
Do you have a story tip? Email: newsroomau@yahoonews.com.
You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
‘I'll use private sector to help clear NHS backlog', says Streeting
Wes Streeting has said he will consider leaning more heavily on the private sector as he bids to clear NHS waiting lists. The health secretary said he will not be 'bound by outdated ideological battles' when tackling the crisis in the service, where 7.39 million people are currently waiting to be seen by doctors. He said it would be 'foolish to turn away' from the private healthcare sector, but cautioned that 'we must see it for what it is'. Writing in the Sunday Telegraph, Mr Streeting said: 'Some ask if using private capacity contradicts NHS principles. Nonsense. What contradicts NHS principles is letting people suffer unnecessarily when capacity exists to treat them. 'The treatment remains free at the point of use – that's what matters. The independent healthcare sector won't affect this principle, and so it would be foolish to turn it away when we so desperately need it in certain specialities. But at the same time, we must see it for what it is.' The health secretary, who previously received treatment for kidney cancer, added: 'Cancer taught me that time is precious. When you're waiting for treatment, every day matters. That's why I won't waste a single day, or a single available appointment slot, in our mission to give patients the care they deserve.' His comments are likely to spark uproar from MPs on the left of the Labour Party, who fiercely opposed expanding the role of the private sector under Jeremy Corbyn. The former Labour leader has previously accused Sir Keir Starmer of 'betraying' the health service for relying more on private care. The government has said partnerships with the private sector under Labour so far have delivered more than 500,000 treatments, with waiting lists having fallen to a two-year low of 7.39 million in April. Darren Grewcock, a security guard, had hip replacement surgery at the Meriden Hospital through a full NHS referral after an injury left him unable to work. He said: 'The X-rays revealed that I had bone-on-bone osteoarthritis on my left hip. I was referred for surgery and given a list of places you can go – which included options in the independent sector. 'Within three days of booking, I had an appointment booked with the consultant. I couldn't believe how quickly he got back to me and the process started. My recovery has been a huge success. I am fitter, stronger, and more mobile than I was at 50." The charity, Patients Association, welcomed the greater role of the private sector in the NHS. Chief executive Rachel Power said: 'As the NHS continues to tackle the backlog, communication and choice must remain central to how care is delivered because patients don't just need treatment, they need to feel informed and empowered.'
Yahoo
4 hours ago
- Yahoo
Soft metal solid-state battery mimics biology, could drive EVs 500 miles per charge
Researchers at Georgia Tech have developed a new metal combination that could transform the future of solid-state batteries. By blending lithium with a soft, surprising element, sodium, the team has found a way to reduce the pressure needed for these batteries to operate significantly. This innovation could lead to lighter, longer-lasting power sources for everything from smartphones to electric vehicles. The findings were published by the lab of Matthew McDowell, a professor in Georgia Tech's School of Mechanical Engineering and the School of Materials Science and Engineering. His group has also filed for a patent on the breakthrough. Solid-state batteries promise greater energy density and better safety than lithium-ion ones. They use a solid electrolyte instead of a flammable liquid, making them more stable. However, they often require high pressure to work. The metal plates needed to apply that pressure are often heavier and bulkier than the battery itself. 'A solid-state battery usually requires metal plates to apply this high pressure, and those plates can be bigger than the battery itself,' McDowell said. 'This makes the battery too heavy and bulky to be effective.' That challenge has kept solid-state batteries from reaching widespread use, despite years of research and hype. The team, led by Georgia Tech research scientist Sun Geun Yoon, found that adding sodium to lithium changes the game. Sodium is not active in the battery's electrochemical process, but its softness plays a key role. 'Adding sodium metal is the breakthrough,' McDowell said. 'It seems counterintuitive because sodium is not active in the battery system, but it's very soft, which helps improve the performance of the lithium.' Sodium's softness is no exaggeration. In a controlled setting, someone could press a gloved finger into the metal and leave a mark. When paired with lithium, it deforms easily under lower pressure, keeping better contact with the solid electrolyte. This improves overall battery performance. To understand why sodium-lithium batteries perform better, the team turned to biology. Specifically, they used the concept of morphogenesis — the way biological structures evolve based on local conditions. Morphogenesis is rare in materials science. But in this case, the interaction between sodium and lithium followed this pattern. The researchers saw that sodium behaved like a deformable phase, adjusting to structural changes during battery use. McDowell's team developed this concept under a project funded by the Defense Advanced Research Projects Agency (DARPA), alongside other universities. The implications of this research are broad. It could lead to phone batteries that last far longer or electric vehicles capable of going 500 miles on a single charge. The ability to reduce the pressure requirement without sacrificing energy capacity opens new possibilities for scaling solid-state batteries. While challenges remain before commercialization, McDowell's group continues to test new materials. Their goal is to make solid-state batteries more competitive with the lithium-ion standard. If successful, this shift could mark a major leap in battery technology. The study is published in the journal Science.
Washington Post
6 hours ago
- Washington Post
Medicaid enrollees fear losing health coverage if Congress enacts work requirements
It took Crystal Strickland years to qualify for Medicaid, which she needs for a heart condition. Strickland, who's unable to work due to her condition, chafed when she learned that the U.S. House has passed a bill that would impose a work requirement for many able-bodied people to get health insurance coverage through the low-cost, government-run plan for lower-income people.
